BioNTech Investor Day Presentation Deck slide image

BioNTech Investor Day Presentation Deck

We are investing in global cGMP cell therapy infrastructures IMFS, Idar-Oberstein, Germany (fully owned) 37712 Advantages of an automated approach 24/7 operational model Reduction of steps and time Reduction of complexity Increased efficiency Manufacturing and automation BioNTech, Gaithersburg, MD, US (long-term lease) 930 Reproducibility of manufacturing process Unlocks capacity Faster turnaround time per patient. Advanced planning algorithms BIONTECH 53
View entire presentation